These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26194619)

  • 1. Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice.
    Nilsson P; Loganathan K; Sekiguchi M; Winblad B; Iwata N; Saido TC; Tjernberg LO
    Proteomics; 2015 Oct; 15(19):3349-55. PubMed ID: 26194619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
    Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo.
    Madani R; Poirier R; Wolfer DP; Welzl H; Groscurth P; Lipp HP; Lu B; El Mouedden M; Mercken M; Nitsch RM; Mohajeri MH
    J Neurosci Res; 2006 Dec; 84(8):1871-8. PubMed ID: 16998901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
    Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease.
    Klein C; Mathis C; Leva G; Patte-Mensah C; Cassel JC; Maitre M; Mensah-Nyagan AG
    Neurobiol Aging; 2015 Feb; 36(2):832-44. PubMed ID: 25457559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
    Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
    FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
    Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
    Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
    Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
    Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
    Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
    Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nobiletin Reduces Intracellular and Extracellular β-Amyloid in iPS Cell-Derived Alzheimer's Disease Model Neurons.
    Kimura J; Shimizu K; Kajima K; Yokosuka A; Mimaki Y; Oku N; Ohizumi Y
    Biol Pharm Bull; 2018; 41(4):451-457. PubMed ID: 29607920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.